Amylin Replacement With Pramlintide as an Adjunct to Insulin Therapy in Type 1 and Type 2 Diabetes Mellitus: A Physiological Approach Toward Improved Metabolic Control

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|7|14|1353-1373

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.7, Iss.14, 2001-09, pp. : 1353-1373

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pramlintide a positive adjunct in type 2 diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1595, 2007-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Individualized selection of insulin therapy helps achieve glycaemic control in type 1 or type 2 diabetes mellitus

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 5, 2008-05 ,pp. : 13-16

Adis International

Access to resources Recommend Favorite

Combination therapy with statin and fibrate in patients with dyslipidemia associated with insulin resistance, metabolic syndrome and type 2 diabetes mellitus

By Reyes-Soffer Gissette   Rondon-Clavo Carlos   Ginsberg Henry N  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 9, 2011-06 ,pp. : 1429-1438

Informa Healthcare

Access to resources Recommend Favorite

Optimising Therapy for Insulin-Treated Type 2 Diabetes Mellitus

By Hermann L.  

Drugs & Aging, Vol. 17, Iss. 4, 2000-10 ,pp. : 283-294

Adis International

Access to resources Recommend Favorite

Adjuvant pramlintide improves glycaemic control in type 1 diabetes

By  

Inpharma, Vol. 1, Iss. 1467, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite